RET and medullary thyroid gland carcinoma: Identification of RET mutations in patients with a diagnosis of MTC is essential, both for index patients and for at-risk relatives, and allows for the potential identification of hereditary MTC patients appearing to have sporadic MTC who are not followed-up regarding other MEN 2A components, especially the life-threatening disease PHEO (1).